LONG-TERM OUTCOME AFTER DISCONTINUATION OF INFLIXIMAB IN PATIENTS WITH CROHN’S DISEASE ACHIEVING CLINICAL REMISSION

(1) KU Leuven



This item was part of the IBD II session at UEG Week 2013

This item can be cited as: United European Gastroenterology Journal; 2013: 1 (Supplement 1) A374

You may be interested in:

QUALITY OF LIFE IN A EUROPEAN INCEPTION COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS IN 2010 - AN ECCO-EPICOM STUDY
English, Inflammatory bowel disease, Abstract, Epidemiology, 'IBD-ology', 2013
IDENTIFICATION OF DISEASE-ASSOCIATED DNA METHYLATION IN BLOOD FROM PATIENTS WITH INFLAMMATORY BOWEL DISEASE
English, Genetics, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013

Categorisation:

  • Clinical Specialty
    • 'IBD-ology'
  • Diagnosis and Management
    • Medical management
  • Disease
    • Inflammatory bowel disease
  • Format
    • Abstract
  • Language
    • English
  • Year
    • 2013